Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02187185 · ClinicalTrials.gov registry record · NA

Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease

A NA study of Inflammation and Periodontitis, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT02187185 is a NA study of Inflammation and Periodontitis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 175 participants, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02187185, a NA study of Inflammation and Periodontitis, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

This research study has 2 aims. One aim is to see if saliva testing can show if a person has healthy gum tissue, gingivitis, or one of three degrees of periodontitis - mild, moderate, or severe. The second aim is to examine the effect of the Sonicare Elite/Flexcare toothbrush on periodontitis.

Interventions

  • OTHER Sonicare/Elite-Flexcare Toothbrush
  • OTHER Manual Toothbrush

Study Locations (1)

North Carolina

  • The University of North Carolina at Chapel Hill School of Dentistry - Chapel Hill

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2009-04
Est. Completion 2012-03
Phase NA

What the Registry Record Tells You About NCT02187185

The ClinicalTrials.gov registry entry for NCT02187185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (39% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Sonicare/Elite-Flexcare Toothbrush is the first listed.

NCT02187185 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02187185 about?

NCT02187185 is a clinical study titled "Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease". This research study has 2 aims. One aim is to see if saliva testing can show if a person has healthy gum tissue, gingivitis, or one of three degrees of periodontitis - mild, moderate, or severe. The second aim is to examine the effect of the Sonicare Elite/Flexcare toothbrush on periodontitis.

What is the current status of trial NCT02187185?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2009-04. Estimated completion is 2012-03.

What conditions does trial NCT02187185 study?

This clinical trial studies the following conditions: Inflammation, Periodontitis.

What interventions are being tested in trial NCT02187185?

The interventions under investigation include: Sonicare/Elite-Flexcare Toothbrush (OTHER), Manual Toothbrush (OTHER).

Who is sponsoring clinical trial NCT02187185?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02187185 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.